Selegiline Transdermal System in Major Depressive Disorder: Profile Report

Author： Frampton James E.   Plosker Greg L.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.21, Iss.6, 2007-01, pp. : 521-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder

By Frampton James E.   Plosker Greg L.  

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder: A Viewpoint by J. Alexander Bodkin

By Bodkin J. Alexander  

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 266-267

Adis International

Access to resources Recommend Favorite

Escitalopram in the Treatment of Major Depressive Disorder in Adolescent Patients†: Profile Report

By Yang Lily P.H.   Scott Lesley J.  

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 621-623

Adis International

Access to resources Recommend Favorite

Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Children: Profile Report

By Anderson Vanessa R.   Scott Lesley J.  

American Journal of Drug Delivery, Vol. 4, Iss. 3, 2006-01 ,pp. : 189-191

Adis International

Access to resources Recommend Favorite

Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Adolescents†: Profile Report

By Keating Gillian M.  

Drugs in R&D, Vol. 12, Iss. 3, 2012-09 ,pp. : 171-173

Adis International

Access to resources Recommend Favorite